| abstract |
Compounds and compositions that can be modulators of MAGL and / or ABHD6, and their use as therapeutic agents, processes for their preparation, and medicaments comprising the disclosed compounds as at least one active agent Provision of the composition. 1,1,1,3,3,3-hexafluoropropan-2-yl 4-((5- (4-methoxyphenyl) isoxazol-3-yl) methyl) piperazine-1-carboxylic acid Carbamate compounds such as salts. [Selection figure] None |